Yantian Tang

Yantian Tang

Auto-generated profile, based on publicly available information

Yantian Tang

Heyuan Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Heyuan 517000, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2023 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YZYang Zhang
Yang Zhang
YTYantian Tang
Yantian Tang
LCLei Cai
Lei Cai
JHJing He
Jing He
LCLingli Chen
Lingli Chen
Wenjun WangWenjun Wang
Wenjun Wang
To investigate the immunomodulatory activities of Chimonanthus nitens Oliv polysaccharides (COP1), an immunosuppressive mouse model was generated by cyclophosphamide (CY) administration and then treated with COP1. The results demonstrated that COP1 ameliorated the body weight and immune organ (spleen and thymus) index of mice and improved the pathological changes of the spleen and ileum induced by CY. COP1 strongly stimulated the production of inflammatory cytokines (IL-10, IL-12, IL-17, IL-1β, and TNF-α) of the spleen and ileum by promoting the mRNA expressions. Furthermore, COP1 had immunomodulatory activity by increasing several transcription factors (JNK, ERK, and P38) in the mitogen-activated protein kinase (MAPK) signaling pathway. Related to the above immune stimulatory effects, COP1 positively affected the production of short-chain fatty acids (SCFAs) and the expression of ileum tight junction (TJ) protein (ZO-1, Occludin-1, and Claudin-1), upregulated the level of secretory immunoglobulin A (SIgA) in the ileum and microbiota diversity and composition, and improved intestinal barrier function. This study suggests that COP1 may provide an alternative strategy for alleviating chemotherapy-induced immunosuppression.

19 September 2026 in Animals
Verified
Journal Article
Open access
PDF file
HXHaiping Xu
Haiping Xu
YTYantian Tang
Yantian Tang
SZSiyu Zhang
Siyu Zhang
GWGuosheng Wang
Guosheng Wang
Escherichia coli (E. coli)-induced enteritis impairs intestinal barrier function, immune homeostasis, and growth performance in broilers. This study investigated whether dietary curcumin alleviates E. coli-induced intestinal injury by modulating macrophage-mediated inflammatory responses through the p38 MAPK signaling pathway. Broilers were fed either a basal or curcumin-supplemented diet and challenged with E. coli. Growth performance, intestinal inflammatory cytokines, morphology, barrier-related gene expression, goblet cell density, and ileal macrophage responses were evaluated. Lipopolysaccharide (LPS)-stimulated HD11 cells were used to examine the underlying mechanism. Curcumin supplementation increased body weight, average daily feed intake, and average daily gain in E. coli-challenged broilers, without significantly affecting the feed conversion ratio. Curcumin also reduced jejunal and ileal IL-1β, IL-6, and TNF-α levels; improved villus morphology and the villus height-to-crypt depth ratio; and upregulated CLDN1, OCLN, ZO-1, and MUC2 expression. In addition, curcumin restored goblet cell density and ileal macrophage abundance while suppressing macrophage-derived pro-inflammatory cytokine expression. In HD11 cells, curcumin inhibited LPS-induced inflammatory cytokine expression and secretion and reduced p38 MAPK phosphorylation, whereas pharmacological activation of p38 partially reversed these effects. In conclusion, dietary curcumin alleviated E. coli-induced enteritis in broilers by suppressing intestinal inflammation, preserving intestinal barrier function, and modulating macrophage-mediated immune responses. In vitro findings further suggest that inhibition of p38 MAPK signaling may contribute to the anti-inflammatory effects of curcumin on chicken macrophages.